NERV (Minerva Neurosciences, Inc.) Stock Financials & Earnings

NERVMinerva Neurosciences, Inc.

Mkt Cap$58M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$14M

EPS (TTM)-$1.85

Free Cash Flow (TTM)-$14M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	$0	-$5M
Q1 23	$0	$0	-$5M
Q2 23	$0	$0	-$5M
Q3 23	$0	$0	-$6M
Q4 23	$0	$0	-$7M
Q1 24	$0	$0	-$7M
Q2 24	$0	$0	-$6M
Q3 24	$0	$0	-$4M
Q4 24	$0	$0	-$5M
Q1 25	$0	$0	-$4M
Q2 25	$0	$0	-$3M
Q3 25	$0	-$1K	-$3M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q4 22	$3M	$2M	—
Q1 23	$3M	$3M	—
Q2 23	$2M	$3M	—
Q3 23	$3M	$3M	—
Q4 23	$5M	$2M	—
Q1 24	$4M	$3M	—
Q2 24	$4M	$2M	—
Q3 24	$2M	$2M	—
Q4 24	$2M	$3M	—
Q1 25	$1M	$3M	—
Q2 25	$1M	$2M	—
Q3 25	$925K	—	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$36M	$0	$36M
Q1 23	$36M	$0	$36M
Q2 23	$52M	$0	$52M
Q3 23	$47M	$0	$47M
Q4 23	$41M	$0	$41M
Q1 24	$35M	$0	$35M
Q2 24	$31M	$0	$31M
Q3 24	$27M	$0	$27M
Q4 24	$21M	$0	$21M
Q1 25	$17M	$0	$17M
Q2 25	$15M	$0	$15M
Q3 25	$12M	$0	$12M

Shares Outstanding

Revenue Per Employee

Revenue / Employee